Vascugen is a regenerative medicine company engaged in the development of advanced therapies to treat incurable conditions caused by loss or degeneration of blood vessels. The company has exclusive, worldwide rights to a broad patent portfolio for its platform technology that enables the functional restoration of blood vessels in any organ or tissue, as well as rights covering related products and services for research, diagnostics, therapeutics, tissue engineering, organoid and 3D bio-printing applications. Driven by innovation and a team of scientific and clinical thought leaders, Vascugen was founded by Dr. Mervin C. Yoder, a pioneer and noted expert in the field of vascular stem cell biology.
| Website | http://www.vascugen.com |
| Employees | 4 (2 on RocketReach) |
| Founded | 2017 |
| Address | 5602 Research Park Blvd, Madison, Wisconsin 53719, US |
| Phone | +1 501-666-3333 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+7 more
(view full list)
|
| Industry | Biotechnology, Science and Engineering |
| Keywords | Regenerative Medicine, Vascular Disease Treatment, Advanced Therapies, Therapeutic Solutions, Tissue Repair, Cell Therapy, Growth Factors, Pharmaceutical Development, Drug Development, Gene Therapy, Stem Cells, Biotechnology, Medical Innovation, Patent Portfolio, Clinical Trials |
| Competitors | CVRx | Barostim, Athersys, Neovasc Inc., CureMetrix, Xeltis, Keystone Heart, A Venus Medtech Company, Endogena Therapeutics, Inc., Correvio International Sàrl, Vasculox, Inc., Angiogen LLC +17 more (view full list) |
Looking for a particular Vascugen employee's phone or email?
2 people are employed at Vascugen.
Vascugen is based in Madison, Wisconsin.